Career history of Clive Morris
Former positions of Clive Morris
| Companies | Position | Start | End |
|---|---|---|---|
Inivata Ltd.
 Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 01/05/2016 | 30/06/2022 |
| Chief Executive Officer | 01/07/2018 | 18/06/2021 | |
| Chief Tech/Sci/R&D Officer | 01/05/2016 | 01/07/2018 | |
| President | 18/06/2021 | 23/05/2022 | |
| NEOGENOMICS, INC. | Corporate Officer/Principal | - | 30/06/2022 |
| CorpHQ, Inc. | Corporate Officer/Principal | - | 06/08/2007 |
| ASTRAZENECA PLC | Public Communications Contact | 06/01/2011 | - |
Training of Clive Morris
| The Royal College of Surgeons of England | Doctorate Degree |
Statistics
International
| United Kingdom | 4 |
| United States | 3 |
Operational
| Corporate Officer/Principal | 2 |
| Public Communications Contact | 1 |
| Doctorate Degree | 1 |
Sectoral
| Communications | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| NEOGENOMICS, INC. | Health Services |
| Private companies | 2 |
|---|---|
| CorpHQ, Inc. | Communications |
Inivata Ltd.
Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Stock Market
- Insiders
- Clive Morris
- Experience
